Diarrheal Disease Treatment: Why It’s Important

Diarrheal Disease is the second leading cause of death of children under 5 years old. Each year around 760,000 children are killed by diarrheal disease, which is both preventable and treatable. It is generally contracted from contaminated food and water sources, resulting in an intestinal infection of a variety of bacteria, viruses, and parasitic organisms. Dehydration is the most severe threat posed by Diarrheal Disease, due to the extreme amount of water and electrolytes that are lost. Once a child reaches a dehydrated stage, they must be treated with Oral Rehydration Solution (ORS), a mixture of water and electrolytes, or given an intravenous dip. Unfortunately, ORS are not always available, and many doctors are reluctant to prescribe them at an early stage because they traditionally do not have any preventative abilities against diarrhea onset. While ORS continues to save millions of lives, it was originally designed to treat dehydration caused by diarrhea and does not treat the disease agents that cause it, like the cholera bacteria, E. coli, and rotavirus. Therefore, a more efficacious formulation to combat disease-causing agents while facilitating the absorption of nutrients and water is greatly needed.

Ray and Somen meet at the International Center for Diarrheal Disease Research, Bangladesh to discuss new Super-ORS

GHS hopes to formulate a new ORS, called Super-ORS which is designed to replace the lost water and electrolytes and fight infection. In order to do this, we have researched the power of breast feeding, which gives children an antimicrobial community and a strong immunity to many diseases. Preliminary studies show that when components of breast milk are added to ORS, the diarrheal disease time can be reduced by one-third. We are collaborating with physicians and researchers from the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) and others to help lessen the burden of diarrheal disease around the world.

See the World Health Organization’s Diarrheal Disease Fact sheet: http://www.who.int/mediacentre/factsheets/fs330/en/


GHS forms official partnership with the International Center for Diarrheal Disease Research, Bangladesh (ICDDR,B)

ICDDR,B, is a world-class international health research institution that is dedicated to saving lives through research, treatment, and education in fields ranging from neonatal care to HIV/AIDS. This partnership provides GHS with access to talented researchers and physicians skilled in conducting human trials in the treatment of acute malnutrition and diarrheal disease.

Meeting with Tahameed Ahmed ICDDR, Bangladesh

On September 25, 2010, members of the Global HealthShare Initiative, met with Dr. Tahameed Ahmed, Head, Nutrition Program and Senior Scientist in the Clinical Sciences Division at the International Center for Diarrheal Disease Research, Dhaka Bangladesh. Continue reading